Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001683168-25-005404
Filing Date
2025-07-25
Accepted
2025-07-25 16:05:30
Documents
15

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT #2 sunshine_posam2.htm   iXBRL POS AM 150824
2 CONSENT OF BUSH & ASSOCIATES CPA LLC sunshine_ex2301.htm EX-23.1 2448
7 GRAPHIC image_001.jpg GRAPHIC 10891
  Complete submission text file 0001683168-25-005404.txt   390001

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sbfm-20250725.xsd EX-101.SCH 3772
4 XBRL DEFINITION FILE sbfm-20250725_def.xml EX-101.DEF 26213
5 XBRL LABEL FILE sbfm-20250725_lab.xml EX-101.LAB 37069
6 XBRL PRESENTATION FILE sbfm-20250725_pre.xml EX-101.PRE 24871
17 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_posam2_htm.xml XML 3807
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-276817 | Film No.: 251151713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)